ArticleEuropean urology2020

Re: Clinical Efficacy and Biomarker Analysis of Neoadjuvant Atezolizumab in Operable Urothelial Carcinoma in the ABACUS Trial.

Gerald B Schulz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.